Delivery Order SPE2DR25D3102-SPE2DR26F2P3F
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,128.12 delivery order on December 3, 2025, for 60 tablets of Corlanor 7.5 mg, a pharmaceutical product used in cardiac care. This is a firm fixed-price, non-set-aside contract with a completion date of December 4, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,110.41 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Corlanor 5 mg tablets (60-unit packages). This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,227.00 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was issued on July 14, 2025, with an ultimate completion date of July 15, 2025. The delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,124.51 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 7.5 mg, a cardiovascular medication. The contract is a firm fixed-price delivery order with an ultimate completion date of November 26, 2025, and was awarded on November 25, 2025 with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,911.92 to AmerisourceBergen Drug Corp for the supply of Corlanor 5 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 19, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competed among qualified vendors in the open...
- The Defense Logistics Agency awarded a $10,382.17 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiovascular medication used to treat heart failure. This firm fixed-price contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a direct purchase from the vendor's existing Indefinite Delivery Contract with DLA. The award involved no set-aside designation and was competitively awarded. Performance will occur at...
- The Defense Logistics Agency awarded a delivery order valued at $2,701.65 to AmerisourceBergen Drug Corp for Corlanor 7.5 mg tablets (60-count) with an ultimate completion date of November 17, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the DLA's medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,718.54 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication used to treat heart failure. The award was made on September 22, 2025, under a firm fixed price contract type with an ultimate completion date of September 23, 2025. This non-set-aside delivery order was performed at the contractor's facility in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement within the...
- The Defense Logistics Agency awarded a $6,147.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, with a completion date of December 2, 2025. This competitively awarded, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,614.57 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 5 mg, a cardiac medication. This firm fixed price, non-set-aside contract was awarded on December 19, 2025, with an ultimate completion date of December 22, 2025. The pharmaceutical supply will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued...
- SPE2DR25D3102Indefinite Delivery Contract
- SPE2DR25D3102-SPE2DR26F2P3FDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,128.12 to AmerisourceBergen Drug Corp for 60 tablets of Corlanor 7.5 mg, a cardiac medication used to treat heart failure. This firm fixed-price delivery order, issued December 5, 2025, represents a non-set-aside, competitively awarded contract with a completion deadline of December 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the contractor to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs globally. The contract serves multiple government customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen Drug Corp as a key vendor within DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/4/25 |